FADDA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 379
EU - Europa 76
AS - Asia 66
Totale 521
Nazione #
US - Stati Uniti d'America 379
CN - Cina 47
UA - Ucraina 25
DE - Germania 14
IT - Italia 14
TR - Turchia 13
GB - Regno Unito 9
SG - Singapore 6
FI - Finlandia 5
SE - Svezia 5
CZ - Repubblica Ceca 3
FR - Francia 1
Totale 521
Città #
Fairfield 62
Woodbridge 49
Ann Arbor 36
Houston 33
Jacksonville 28
Seattle 27
Chandler 22
Cambridge 20
Wilmington 18
Ashburn 14
Beijing 13
Milan 7
Kunming 6
Shanghai 6
Boardman 5
Izmir 5
Princeton 5
San Mateo 5
Ferrara 4
San Diego 4
Singapore 4
Brno 3
Jiaxing 3
Ningbo 3
Tappahannock 3
Auburn Hills 2
Hebei 2
Jinan 2
Los Angeles 2
Mountain View 2
Munich 2
Nanchang 2
Nanjing 2
New York 2
Norwalk 2
Philadelphia 2
Redmond 2
Shenyang 2
Bari 1
Bremen 1
Changsha 1
Dearborn 1
Falls Church 1
Indiana 1
Leawood 1
Redwood City 1
San Francisco 1
Zhengzhou 1
Totale 421
Nome #
The MDM-2 antagonist nutlin-3 promotes the maturation of acute myeloid leukemic blasts 111
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 104
null 89
null 86
null 83
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 29
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 15
Recombinant TRAIL induces miorelaxating activity in rat aortas, which is abrogated by the induction of diabetes mellitus 11
Totale 528
Categoria #
all - tutte 2.162
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.162


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020130 0 6 6 22 10 15 11 14 13 16 12 5
2020/202174 7 7 1 8 7 5 1 9 2 9 12 6
2021/202247 2 4 6 0 1 5 3 3 3 5 2 13
2022/202354 3 3 0 6 11 6 5 6 8 0 3 3
2023/202424 3 3 0 0 1 2 1 2 2 0 0 10
2024/20257 1 6 0 0 0 0 0 0 0 0 0 0
Totale 528